Stock Analysis·← Pickers

NCEL

NewcelX Ltd.

NewcelX Ltd. (NCEL) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 58.6, with 1/3 trend checks passing.

Price
$3.93
-0.05 (-1.26%)
Day range
$3.77–$4.07
52wk $1.83–$28.03
Volume
27.4K
Avg
Trend score
1/3
Range / Mixed
RSI (14)
58.6
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

NCEL with MA50 and MA200

27.9021.3914.898.381.8807/3110/2401/2204/1707/15
NCEL2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$3.47+13.18% vs price
MA200
$4.82-18.46% vs price
RSI (14)
58.6Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Valuation

NCEL valuation multiples (TTM)

P/E Ratio
P/S Ratio
P/B Ratio
EV/EBITDA
Valuation multiples are provided by Financial Modeling Prep when available.
Analyst Ratings

NCEL analyst consensus

Avg Price Target
High Target
Low Target
Analyst Coverage
Analyst ratings and price targets are provided by Financial Modeling Prep when available.
Chart Summary
Trend summary for NCEL

NewcelX Ltd. (NCEL) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $3.93, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 13.2% and below the 200-day moving average by 18.5%.

Momentum and stretch context

NCEL currently has an RSI reading of 58.6, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

This page is designed to help you quickly understand what the NCEL chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About NewcelX Ltd.

NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.

Sector
Healthcare
Industry
Biotechnology
CEO
Ronen Twito
Employees
11
Market cap
$1.7M
Beta
0.92
52-week range
$1.83 – $28.03
Dividend
No
Exchange
NASDAQ
Country
CH
IPO date
24 Oct 2025
ISIN
CH1442297896
CUSIP
H5835A109
Company profile data from Financial Modeling Prep. NCEL listed on NASDAQ.
Share dilution

NCEL shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2017Dec 2025
Shares outstanding (latest)
3.4M
Since Jun 2017
+217.8%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. NCEL18 data points from Jun 2017 to Dec 2025.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about NCEL

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.